Código QR

Factors influencing the selection of an SGLT2i vs. a GLP-1RA as cardioprotective agent in patients with type 2 diabetes

PurposeSodium glucose co-transporter-2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) have demonstrated cardioprotective effects in people with type 2 diabetes and atherosclerotic cardiovascular disease (ASCVD). In this patient group, there is treatment equipoise, from...

ver descrição completa

Na minha lista:
Principais autores: Shubham Agarwal, Mujeeb A. Basit, Michael E. Bowen, Daniel F. Heitjan, Christine Mai, Kelsea Marble, Jonathan Pak, Zichang Xiang, Ildiko Lingvay
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2025-05-01
Colecção:Frontiers in Cardiovascular Medicine
Assuntos:
SGLT2i
GLP-1RA
cardiovascular disease
type 2 diabetes
predictors
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fcvm.2025.1606198/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados